2026-03-17 10:06:36
PURE Bioscience Reports Q2 2026 Financial Results with Increased Sales
Expected Stock impact: Slightly Positive
On March 16, 2026, PURE Bioscience, Inc. (OTCQB: PURE) announced its financial results for the fiscal second quarter ended January 31, 2026. The company reported net product sales of $443,000, an increase from $391,000 in the same quarter of the previous year, reflecting a growth of $52,000 attributed to increased sales across its end-user network. Despite this positive sales growth, the company reported a net loss of $785,000 for the quarter, slightly improved from a net loss of $798,000 in the prior year. The decrease in net loss was supported by a reduction in selling, general, and administrative expenses, which fell by $24,000 due to lower board fees and personnel costs. However, this was offset by increased interest expenses related to the company's notes payable balance. The company also highlighted its ongoing efforts to launch its new product, PURE Clean, which has received USDA Biobased Product Certification and is expected to officially launch in the fiscal third quarter. Additionally, PURE is expanding its marketing efforts targeting dairy farmers and exploring new opportunities in the biomedical space. The overall outlook remains cautiously optimistic as the company continues to validate its products and expand its market reach.
